BioCentury | Mar 8, 2021
Deals

March 8 Quick Takes: Roivant to acquire Immunovant; plus Lilly-Biolojic, Soleno, Gilead, Genentech and Cara-Vifor

...Inc. (NASDAQ:IMVT) rose $1.88 (14%) to $15.39 on Monday after the autoimmune company said parent Roivant Sciences Ltd....
...Tecentriq (Other), Anti-PDL1 (Other) Korsuva, difelikefalin (IV CR845) batoclimab (IMVT-1401, RVT-1401, HL161, HBM9161) Genentech Inc. Gilead Sciences Inc. Soleno Therapeutics Inc. Roivant Sciences Ltd. Cara...
BioCentury | Feb 27, 2021
Deals

Feb. 26 Quick Takes: Venrock leads Artiva’s crossover-laden $120M series B; plus Roivant-Silicon, Origin, Sino-Akeso, Tricida, LISCure

...institutional investors, VCs and KOSDAQ-listed companies.TARGETSPD-1 (PDCD1; CD279) - Programmed cell death 1 Jeff Cranmer Venrock Artiva Biotherapeutics Inc. Roivant Sciences Ltd. Silicon...
BioCentury | Jan 27, 2021
Management Tracks

Novartis’ chief digital officer stepping down; plus moves at Taysha, Roivant, Faze and more

...acquired by Astellas Pharma Inc. (Tokyo:4503) in December 2019.Vivek Ramaswamy stepped down as CEO of Roivant Sciences Ltd....
BioCentury | Dec 8, 2020
Deals

Dec. 7 Quick Takes: Sino pays $515M for Sinovac stake; plus BioCryst, Roivant, AbCellera, Syros, YZY, Maze

...Alloy, named Broadwing Bio, is developing mAbs. Financial terms were not disclosed. BC Staff Maze Therapeutics AbCellera Biologics Inc. Roivant Sciences Ltd. BioCryst...
BioCentury | Nov 21, 2020
Product Development

Nov. 20 Quick Takes: uniQure hemophilia therapy hits pivotal endpoint; plus data from Gilead in HIV, Aivita  in GBM and a setback for Poxel

...not start a Phase III program of imeglimin, citing strategic reasons. Metavant, a spinout of Roivant Sciences Ltd., holds...
BioCentury | Nov 13, 2020
Deals

Nov. 12 Quick Takes: MorphoSys, UCB bring in new tech via deals; plus Cevec-Roche, Bridge-BI, Affimed-Roivant, Insilico-J&J, TCR2-ElevateBio

...front for rights to ENPP2 inhibitor BBT-877. Affimed, Roivant in ICE deal Affimed N.V. (NASDAQ:AFMD) partnered with Roivant Sciences...
...and gene therapy.TargetsENPP2 (ATX) - autotaxin BC Staff BBT-877 Insilico Medicine Inc. Johnson & Johnson Cevec Pharmaceuticals GmbH ElevateBio LLC Boehringer Ingelheim GmbH Roivant Sciences Ltd. Affimed...
BioCentury | Jul 24, 2020
Politics, Policy & Law

Moderna says commercial path remains clear despite unfavorable patent ruling

...bulk of its LNP technology, including ‘069, to Genevant. Arbutus launched Genevant in collaboration with Roivant Sciences...
BioCentury | Mar 19, 2020
Product Development

Roivant pivots towards ARDS in COVID-19; plus Italian studies of repurposed anti-inflammatories, vaccine updates and more

...COVID-19, while HHS launched a new public-private partnership to ramp up emergency drug packaging capabilities. Roivant Sciences...
...Johnson Quidel Corp. BGI Genomics Co. Ltd. Mesa Biotech Inc. U.S. Department of Health and Human Services Synairgen plc Pulmotect Inc. IMV Inc. Roivant Sciences Ltd. Interleukin-1...
BioCentury | Jan 25, 2020
Company News

Management tracks: Galapagos promotes Manto to CCO; plus Guardant, Horizon, Acceleron, Lilly, Krystal, Kura and more

...a seed round to develop cell therapies for cancer. The Dermavant Sciences dermatology subsidiary of Roivant Sciences...
...L.P. BioCentury Staff Guardant Health Inc. Krystal Biotech Inc. CytoSeek Ltd. Ergomed plc Galapagos N.V. Acceleron Pharma Inc. Eli Lilly and Co. Kura Oncology Inc. Roivant Sciences Ltd....
BioCentury | Jan 16, 2020
Company News

Jan. 15 Company Quick Takes: Japan Tobacco gets rights to Dermavant therapy; plus Clovis, BMS, Recordati, BeiGene, Insilico-Pfizer, Novartis

...develop and commercialize tapinarof in Japan for dermatology indications including psoriasis and atopic dermatitis. The Roivant Sciences...
...Generic), Yervoy (Other) Insilico Medicine Inc. Pfizer Inc. NHS England Novartis AG EUSA Pharma Ltd. BeiGene Ltd. Japan Tobacco Inc. Clovis Oncology Inc. Recordati S.p.A. Roivant Sciences Ltd. Bristol...
Items per page:
1 - 10 of 122
BioCentury | Mar 8, 2021
Deals

March 8 Quick Takes: Roivant to acquire Immunovant; plus Lilly-Biolojic, Soleno, Gilead, Genentech and Cara-Vifor

...Inc. (NASDAQ:IMVT) rose $1.88 (14%) to $15.39 on Monday after the autoimmune company said parent Roivant Sciences Ltd....
...Tecentriq (Other), Anti-PDL1 (Other) Korsuva, difelikefalin (IV CR845) batoclimab (IMVT-1401, RVT-1401, HL161, HBM9161) Genentech Inc. Gilead Sciences Inc. Soleno Therapeutics Inc. Roivant Sciences Ltd. Cara...
BioCentury | Feb 27, 2021
Deals

Feb. 26 Quick Takes: Venrock leads Artiva’s crossover-laden $120M series B; plus Roivant-Silicon, Origin, Sino-Akeso, Tricida, LISCure

...institutional investors, VCs and KOSDAQ-listed companies.TARGETSPD-1 (PDCD1; CD279) - Programmed cell death 1 Jeff Cranmer Venrock Artiva Biotherapeutics Inc. Roivant Sciences Ltd. Silicon...
BioCentury | Jan 27, 2021
Management Tracks

Novartis’ chief digital officer stepping down; plus moves at Taysha, Roivant, Faze and more

...acquired by Astellas Pharma Inc. (Tokyo:4503) in December 2019.Vivek Ramaswamy stepped down as CEO of Roivant Sciences Ltd....
BioCentury | Dec 8, 2020
Deals

Dec. 7 Quick Takes: Sino pays $515M for Sinovac stake; plus BioCryst, Roivant, AbCellera, Syros, YZY, Maze

...Alloy, named Broadwing Bio, is developing mAbs. Financial terms were not disclosed. BC Staff Maze Therapeutics AbCellera Biologics Inc. Roivant Sciences Ltd. BioCryst...
BioCentury | Nov 21, 2020
Product Development

Nov. 20 Quick Takes: uniQure hemophilia therapy hits pivotal endpoint; plus data from Gilead in HIV, Aivita  in GBM and a setback for Poxel

...not start a Phase III program of imeglimin, citing strategic reasons. Metavant, a spinout of Roivant Sciences Ltd., holds...
BioCentury | Nov 13, 2020
Deals

Nov. 12 Quick Takes: MorphoSys, UCB bring in new tech via deals; plus Cevec-Roche, Bridge-BI, Affimed-Roivant, Insilico-J&J, TCR2-ElevateBio

...front for rights to ENPP2 inhibitor BBT-877. Affimed, Roivant in ICE deal Affimed N.V. (NASDAQ:AFMD) partnered with Roivant Sciences...
...and gene therapy.TargetsENPP2 (ATX) - autotaxin BC Staff BBT-877 Insilico Medicine Inc. Johnson & Johnson Cevec Pharmaceuticals GmbH ElevateBio LLC Boehringer Ingelheim GmbH Roivant Sciences Ltd. Affimed...
BioCentury | Jul 24, 2020
Politics, Policy & Law

Moderna says commercial path remains clear despite unfavorable patent ruling

...bulk of its LNP technology, including ‘069, to Genevant. Arbutus launched Genevant in collaboration with Roivant Sciences...
BioCentury | Mar 19, 2020
Product Development

Roivant pivots towards ARDS in COVID-19; plus Italian studies of repurposed anti-inflammatories, vaccine updates and more

...COVID-19, while HHS launched a new public-private partnership to ramp up emergency drug packaging capabilities. Roivant Sciences...
...Johnson Quidel Corp. BGI Genomics Co. Ltd. Mesa Biotech Inc. U.S. Department of Health and Human Services Synairgen plc Pulmotect Inc. IMV Inc. Roivant Sciences Ltd. Interleukin-1...
BioCentury | Jan 25, 2020
Company News

Management tracks: Galapagos promotes Manto to CCO; plus Guardant, Horizon, Acceleron, Lilly, Krystal, Kura and more

...a seed round to develop cell therapies for cancer. The Dermavant Sciences dermatology subsidiary of Roivant Sciences...
...L.P. BioCentury Staff Guardant Health Inc. Krystal Biotech Inc. CytoSeek Ltd. Ergomed plc Galapagos N.V. Acceleron Pharma Inc. Eli Lilly and Co. Kura Oncology Inc. Roivant Sciences Ltd....
BioCentury | Jan 16, 2020
Company News

Jan. 15 Company Quick Takes: Japan Tobacco gets rights to Dermavant therapy; plus Clovis, BMS, Recordati, BeiGene, Insilico-Pfizer, Novartis

...develop and commercialize tapinarof in Japan for dermatology indications including psoriasis and atopic dermatitis. The Roivant Sciences...
...Generic), Yervoy (Other) Insilico Medicine Inc. Pfizer Inc. NHS England Novartis AG EUSA Pharma Ltd. BeiGene Ltd. Japan Tobacco Inc. Clovis Oncology Inc. Recordati S.p.A. Roivant Sciences Ltd. Bristol...
Items per page:
1 - 10 of 122